المؤلفون: Gregory G. Schwartz, Jeroen V. Koomen, Diederick E. Grobbee, Anders Svensson, Jasper Stevens, Arlette Weichert, Ilse C. Schrieks, Stephen J. Nicholls, Hiddo J.L. Heerspink, Hans Wedel, A. Michael Lincoff

المساهمون: Real World Studies in PharmacoEpidemiology, -Genetics, -Economics and -Therapy (PEGET), Groningen Kidney Center (GKC), Methods in Medicines evaluation & Outcomes research (M2O)

المصدر: Diabetes obesity & metabolism. Wiley
Diabetes, Obesity & Metabolism
Diabetes, Obesity & Metabolism, 22(1), 30. Wiley-Blackwell

مصطلحات موضوعية: Male, PHARMACOKINETICS, Endocrinology, Diabetes and Metabolism, 030204 cardiovascular system & hematology, Gastroenterology, ACUTE CORONARY SYNDROME, law.invention, chemistry.chemical_compound, 0302 clinical medicine, Endocrinology, Randomized controlled trial, law, Risk Factors, Drug Interactions, ALPHA/GAMMA AGONIST, Oxazoles, education.field_of_study, Aspirin, Aleglitazar, Middle Aged, Clopidogrel, Diabetes and Metabolism, PK‐PD, Cardiovascular Diseases, CLOPIDOGREL, Female, Original Article, medicine.drug, Acute coronary syndrome, medicine.medical_specialty, Population, TYPE-2 DIABETES-MELLITUS, 030209 endocrinology & metabolism, Thiophenes, METABOLISM, Placebo, exposure response, EVENTS, 03 medical and health sciences, Double-Blind Method, Internal medicine, Journal Article, Internal Medicine, medicine, Humans, PPAR alpha, peroxisome proliferator‐activated receptor, education, Aged, Creatinine, peroxisome proliferator-activated receptor, business.industry, PK-PD, Original Articles, medicine.disease, PPAR gamma, ASPIRIN, chemistry, Diabetes Mellitus, Type 2, Heart Disease Risk Factors, randomized controlled trial, aleglitazar, business

وصف الملف: application/pdf; text/plain; image/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc202069c56b7294f9501cd2ae079986Test
https://research.rug.nl/en/publications/91697dcf-2be2-4f05-9909-8444c6790f10Test

المؤلفون: Marcus Lind, Hans Wedel, Sofia Dahlqvist, Soffia Gudbjörnsdottir, Aldina Pivodic, Ann-Marie Svensson, Annika Rosengren, Mikhail Kosiborod

المصدر: The Lancet Diabetes & Endocrinology. 5:799-807

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Adolescent, Endocrinology, Diabetes and Metabolism, Population, 030209 endocrinology & metabolism, 030204 cardiovascular system & hematology, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Endocrinology, Swedish population, Risk Factors, Diabetes mellitus, Internal medicine, Atrial Fibrillation, Internal Medicine, medicine, Humans, Prospective Studies, education, Aged, Type 1 diabetes, education.field_of_study, Patient registry, business.industry, Hazard ratio, Case-control study, Atrial fibrillation, Middle Aged, medicine.disease, Diabetes Mellitus, Type 1, Case-Control Studies, Physical therapy, Female, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1df521437081a44be3d9fe853aa3efbTest
https://doi.org/10.1016/s2213-8587Test(17)30262-0

المؤلفون: Finn Waagstein, Michel Komajda, Hans Wedel, John Kjekshus, John J.V. McMurray, John Wikstrand, Kevin Damman, John G.F. Cleland

المصدر: European Journal of Heart Failure. 18:328-336

مصطلحات موضوعية: medicine.medical_specialty, Ejection fraction, business.industry, medicine.drug_class, medicine.medical_treatment, Hazard ratio, Furosemide, Renal function, 030204 cardiovascular system & hematology, Loop diuretic, medicine.disease, 03 medical and health sciences, 0302 clinical medicine, Endocrinology, Heart failure, Internal medicine, Cardiology, Medicine, Rosuvastatin, 030212 general & internal medicine, Diuretic, Cardiology and Cardiovascular Medicine, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::91c5fdaafa137377498c43719f9febdbTest
https://doi.org/10.1002/ejhf.462Test

المؤلفون: Erik Schwarcz, William H. Polonsky, Tim Heise, Magnus Wijkman, Jan Bolinder, Sofia Dahlqvist, Jarl Hellman, Irl B. Hirsch, Arndís F. Ólafsdóttir, Hans Wedel, Thomas Nyström, Marcus Lind

المصدر: Diabetes Technology & Therapeutics

مصطلحات موضوعية: Adult, Blood Glucose, Male, Pediatrics, medicine.medical_specialty, endocrine system diseases, Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, Type 1 diabetes mellitus, 030209 endocrinology & metabolism, 030204 cardiovascular system & hematology, Hypoglycemia, Nocturnal, Endocrinology and Diabetes, law.invention, 03 medical and health sciences, 0302 clinical medicine, Endocrinology, Randomized controlled trial, law, Diabetes mellitus, Humans, Hypoglycemic Agents, Insulin, Medicine, Continuous glucose monitoring, Glycemic, Glycated Hemoglobin, Type 1 diabetes, Cross-Over Studies, integumentary system, business.industry, Blood Glucose Self-Monitoring, nutritional and metabolic diseases, Hypoglycemia fear, Original Articles, Middle Aged, medicine.disease, Medical Laboratory Technology, Diabetes Mellitus, Type 1, Endokrinologi och diabetes, Quality of Life, Female, Randomized clinical trial, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db98fe36e7e1fd21621d739f70122fccTest
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-351633Test

المؤلفون: Bruce Neal, A. Michael Lincoff, Gregory G. Schwartz, Klas Malmberg, Stephen J. Nicholls, Anders Svensson, Jean-Claude Tardif, Diederick E. Grobbee, Linda Mellbin, Anna Nozza, Barbara E. Stähli, Ilse C. Schrieks, Arlette Weichert, John B. Buse, Lars Rydén, Hans Wedel

المساهمون: University of Zurich, Stähli, Barbara E

المصدر: The Journal of clinical endocrinology and metabolism. 103(7)

مصطلحات موضوعية: Male, 1303 Biochemistry, endocrine system diseases, Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, Clinical Biochemistry, Type 2 diabetes, 1308 Clinical Biochemistry, 030204 cardiovascular system & hematology, Biochemistry, chemistry.chemical_compound, 0302 clinical medicine, Endocrinology, Risk Factors, Natriuretic Peptide, Brain, Homeostasis, Insulin, 030212 general & internal medicine, Myocardial infarction, Oxazoles, Aleglitazar, Middle Aged, 1310 Endocrinology, 2712 Endocrinology, Diabetes and Metabolism, 10209 Clinic for Cardiology, Cardiology, Female, medicine.medical_specialty, Acute coronary syndrome, 610 Medicine & health, Thiophenes, 2704 Biochemistry (medical), Risk Assessment, Endocrinology & Metabolism, 03 medical and health sciences, Insulin resistance, Internal medicine, Diabetes mellitus, medicine, Humans, Hypoglycemic Agents, cardiovascular diseases, Acute Coronary Syndrome, Aged, Proportional Hazards Models, business.industry, Biochemistry (medical), nutritional and metabolic diseases, Type 2 Diabetes Mellitus, 1103 Clinical Sciences, medicine.disease, Survival Analysis, Peptide Fragments, chemistry, Diabetes Mellitus, Type 2, 1114 Paediatrics and Reproductive Medicine, Insulin Resistance, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::529350a4c3b8475cec180328d2daa345Test
https://pubmed.ncbi.nlm.nih.gov/29659887Test

المؤلفون: Jan H. Cornel, Finn Waagstein, John J.V. McMurray, Timo Kuusi, Hans Wedel, Åke Hjalmarson, Peter H.J.M. Dunselman, Johan Vanhaecke, Magnus Lindberg, John Kjekshus, John G.F. Cleland, Michel Komajda, John Wikstrand

المصدر: European Journal of Heart Failure. 11:281-291

مصطلحات موضوعية: Male, Administration, Oral, 030204 cardiovascular system & hematology, chemistry.chemical_compound, 0302 clinical medicine, Risk Factors, Cause of Death, Natriuretic Peptide, Brain, Natriuretic peptide, Medicine, 030212 general & internal medicine, Rosuvastatin Calcium, 2. Zero hunger, Sulfonamides, Ejection fraction, Prognosis, 3. Good health, Survival Rate, C-Reactive Protein, Valsartan, Cardiology, Female, Cardiology and Cardiovascular Medicine, medicine.drug, medicine.medical_specialty, medicine.drug_class, Renal function, Drug Administration Schedule, 03 medical and health sciences, Nephelometry and Turbidimetry, Internal medicine, Humans, Clinical Trials, Rosuvastatin, Protein Precursors, Aged, Heart Failure, Creatinine, Apolipoprotein A-I, Dose-Response Relationship, Drug, business.industry, medicine.disease, Peptide Fragments, Fluorobenzenes, Pyrimidines, Endocrinology, chemistry, Heart failure, Hydroxymethylglutaryl-CoA Reductase Inhibitors, business, Biomarkers

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f092fba3e21a92bddabedb312345f112Test
https://doi.org/10.1093/eurjhf/hfn046Test